Blood Glucose Monitoring Systems Market – Global Forecasts upto 2024
- June, 2018
- Domain: Healthcare - Medical Devices
- Get Free 10% Customization in this Report
The market for blood glucose monitoring systems is driven by increasing incidence of diabetes across various geographies, huge surge in the aging population, and increasing product launch and approvals. Increasing collaboration and funding to develop innovative devices and raising awareness among the patients are providing an opportunity for the market growth. Product recalls and inadequate reimbursements are few of the factors that may hamper the market growth to an extent.
Market Analysis: The “Global Blood Glucose Monitoring Systems” market is estimated to witness a CAGR of 6.7% during the forecast period 2018–2024. The global market is analyzed based on four segments – products, applications, end-users, and regions.
Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (RoW). North America is the major shareholder in the global blood glucose monitoring systems market, followed by Europe. The Asia Pacific region is expected to grow at a high CAGR during the forecast period due to an upsurge in access to health care services, increasing patient pool, raising awareness among patients, and growing healthcare expenditure. According to the Asian Diabetes Prevention Initiative, nearly 60% of the total diabetic population resides in Asia. It also estimates that 65.1 million adults in India and 113.9 million adults in China have diabetes.
Product Analysis: The blood glucose monitoring systems market, by product, is segmented into self-monitoring blood glucose (SMBG) systems and continuous glucose monitoring (CGM) systems. SMBG systems occupied a significant market share in 2017, and CGM systems are expected to grow at a high CAGR during the forecast period. Increasing adoption of minimally invasive procedures makes it the fastest growing segment during the forecast period.
Application Analysis: The market, by applications, is segmented into type 1 diabetes, type 2 diabetes, and gestational diabetes. Type 2 diabetes occupied a significant market share in 2017 and is expected to remain the same for the next 5 years. This is due to growing patient base for type 2 diabetes and increasing launch of the advanced product in this segment.
End-users Analysis: The market, by end-users, is segmented into hospitals, homecare, private clinics, and others. Among various end-users, homecare occupied a significant market share and is expected to remain the same during the forecast period.
Key Players: Medtronic plc, Johnson and Johnson, Abbott Laboratories, F. Hoffmann-La Roche Ltd., PHC Holdings Corporation, Ypsomed Holding, Dexcom, Acon Laboratories, Trividia Health Inc., Arkray Inc., Sanofi S.A., Terumo Medical Corporation, Prodigy Diabetes Care LLC, and niche players.
Competitive Analysis: The market has a large number of medium and small players that offer innovative products and has immense growth opportunity, especially in the emerging countries. The key market players are taking advantage of product approvals and new product launches, making their strategies to increase the market share. For instance, in September 2017, the US FDA approved FreeStyle Libre Flash Glucose Monitoring System, the first continuous glucose monitoring system that can be used by adult patients to make diabetes treatment decisions without calibration using a blood sample from the fingertip. In February 2018, Roche Diabetes Care India announced the launch of its new glucometer Accu-Chek Instant S, which marks the entry of the organization into the mass market segment in diabetes self-monitoring.
Benefits: The report provides complete details about the usage and adoption rate of blood glucose monitoring systems in various therapeutic verticals and regions. With that, key stakeholders can know about the major trends, drivers, investments, and vertical player’s initiatives. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.
1.1 Market Overview
1.2 Total Addressable Market
2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 Market Snapshot
3.1 Market Definition – Infoholic Research
3.2 Advantages of Blood Glucose Monitoring Systems
3.3 Segmented Addressable Market (SAM)
3.4 Trends of the Blood Glucose Monitoring Systems Market
3.5 Related Markets
3.5.1 Insulin Pump
3.5.2 Smart Insulin Pen
3.5.3 Insulin Syringes
4 Market Outlook
4.1 Evolution of Blood Glucose Monitoring
4.2 Market Segmentation
4.3 PEST Analysis
4.4 Porter 5 (Five) Forces
5 Market Characteristics
5.1 DRO – Global Blood Glucose Monitoring Systems Market Dynamics
220.127.116.11 Increasing incidence of diabetes across various geographies
18.104.22.168 Increasing number of product launch and approvals
22.214.171.124 Huge surge in the aging population
126.96.36.199 New collaboration and funding to develop new devices
188.8.131.52 Growing patient awareness
184.108.40.206 High cost and inadequate reimbursement
220.127.116.11 Product recalls
5.2 DRO – Impact Analysis
5.3 Key Stakeholders
6 Products: Market Size & Analysis
6.2 Self-monitoring Blood Glucose Systems
6.3 Continuous Blood Glucose Monitoring Systems
7 Application: Market Size & Analysis
7.2 Type 1 Diabetes
7.3 Type 2 Diabetes
7.4 Gestational Diabetes
8 End-Users: Market Size and Analysis
8.4 Private Clinics
9 Regions: Market Size and Analysis
9.2 North America
9.4 Asia Pacific
9.5 Rest of the World
10 Competitive Landscape
11 Vendor Profiles
11.1 Medtronic plc
11.1.2 Medtronic plc: Recent Developments
11.1.3 Business Units
11.1.4 Geographic Revenue
11.1.5 Business Focus
11.1.6 SWOT Analysis
11.1.7 Business Strategies
11.2 Abbott Laboratories
11.2.2 Abbott Laboratories: Recent Developments
11.2.3 Business Units
11.2.4 Geographic Revenue
11.2.5 Business Focus
11.2.6 SWOT Analysis
11.2.7 Business Strategies
11.3 Johnson and Johnson
11.3.2 Business Units
11.3.3 Geographic Revenue
11.3.4 Business Focus
11.3.5 SWOT Analysis
11.3.6 Business Strategies
11.4 F. Hoffmann-La Roche Ltd.
11.4.2 Business Units
11.4.3 Geographic Revenue
11.4.4 Business Focus
11.4.5 SWOT Analysis
11.4.6 Business Strategy
12 Companies to Watch for
12.2 PHC Holdings Corporation
12.3 Ypsomed Holding
12.4 B. Braun Melsungen AG
12.5 Trividia Health Inc.
12.6 Acon Laboratories
12.7 Sanofi S.A.
12.8 Arkray, Inc.
12.9 Nova Biomedical Corporation
12.10 Prodigy Diabetes Care, LLC
12.11 Terumo Medical Corporation
Infoholic Research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:
- Data Collation (Primary & Secondary)
- In-house Estimation (Based on proprietary data bases and Models)
- Market Triangulation
Market related information is congregated from both primary and secondary sources.
Involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.
Include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.